Real-world EHR data suggest ACE inhibitor use is independently associated with lower all-cause mortality in idiopathic pulmonary fibrosis, while no similar survival association was observed in COPD.

Among patients with idiopathic pulmonary fibrosis, the risk for all-cause mortality was significantly lower with vs. without angiotensin-converting enzyme inhibitor use started within 5 years before ...

Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...

ACE inhibitor use was associated with reduced all cause mortality in idiopathic pulmonary fibrosis in a matched real world ...

Research has shown that angiotensin converting enzyme (ACE) inhibitors help manage diabetic nephropathy-related issues. They can also slow the progression of diabetic nephropathy in some people.

The prognostic impact of KRAS mutation in colorectal cancer patients: A meta-analysis of phase III clinical trials. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract ...

Within the renin-angiotensin system (RAS), which regulates blood volume, electrolyte balance, and systemic vascular resistance within the body, the angiotensin-converting enzyme 2 (ACE2) cleaves ...